PharmaShots | Incisive News in 3 Shots

Subscribe Now

Pre-Clinical

Celltrion Reports Results of Regdanvimab (CT-P59) in Pre-Clinical Study Against the South African Variant (B.1.351)

Celltrion Reports Results of Regdanvimab (CT-P59) in Pre-Clinical Study Against the South African Variant (B.1.351)

April 30, 2021

Evotec Signs an Agreement with Celmatix to Develop Pre-Clinical Candidates for Women Health

Evotec Signs an Agreement with Celmatix to Develop Pre-Clinical Candidates for Women Health

October 10, 2019

Jazz Pharmaceuticals Acquires Redx Pharma's Pre-clinical Pan-RAF Inhibitor Program for RAF and RAS Mutant Tumors

Jazz Pharmaceuticals Acquires Redx Pharma's Pre-clinical Pan-RAF Inhibitor Program for RAF and RAS Mutant Tumors

July 10, 2019

Lilly Acquires Hydra Biosciences with its Pre-Clinical Pain Program for Chronic Pain Syndromes

Lilly Acquires Hydra Biosciences with its Pre-Clinical Pain Program for Chronic Pain Syndromes

December 17, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us